MedTrace Logo

Multicenter Cohort Study of AAV in Hunan of China

NCT05315141 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-04-07

No results posted yet for this study

Summary

This study aimed to explore the incidence of Anti-neutrophil cytoplasmic antibody (ANCA）-associated vasculitis (AAV) progression and its association with adverse consequences. It will enroll approximately 500 AAV patients in Hunan province of China and follow-up for at least 5 years. Demographic characteristics, clinical and laboratory data will be collected at baseline and every follow-up. The principal clinical outcomes of the study consist of end stage renal disease (ESRD) and death.

Conditions

  • ANCA Associated Vasculitis

Interventions

OTHER

No Intervention

No Intervention

Sponsors & Collaborators

  • Central South University

    collaborator OTHER

  • The Third Xiangya Hospital of Central South University

    collaborator OTHER

  • Hunan Provincial People's Hospital

    collaborator OTHER

  • Xiangtan Central Hospital

    collaborator OTHER

  • Xiangya Hospital of Central South University

    lead OTHER

Principal Investigators

  • Xiangcheng Xiao, doctor · Xiangya Hospital of Central South University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-16
Primary Completion
2027-03-16
Completion
2027-03-16

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05315141 on ClinicalTrials.gov